Hester Wilson
Biographic Data
| ID | 5570143 |
|---|---|
| NAME | Hester Wilson |
| GIVEN NAMES | Hester |
| FAMILY NAME | Wilson |
| SIGNATURE | WILSON H |
| AFFILIATIONS | Drug and Alcohol Services, South East Sydney Local Health District, Sydney, NSW, Australia |
| ORCID | 0000-0001-7193-9566 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Experiences and Predictors of Real‐Time Prescription Drug Monitoring Program Use Among Australian Community Pharmacists
Management of Opioid Withdrawal Syndrome and Commencement of Opioid Dependence Treatment Following Chronic Use of a Vaping Product Containing Protonitazene
The Whole Structure Is Knackered, It Could Still Explode, It Really Could”
Opioid dependence is a chronic health condition with significant public health implications. Opioid dependence treatment (ODT) has evolved considerably over time. In New South Wales, Australia, ODT prescribing has been available since 1970, managed by both state health services and private practitioners, mostly general practitioners (GPs). This study investigated how various health initiatives influenced GP engagement in ODT prescribing in New So…
What do general practitioners want from specialist alcohol and other drug services? A qualitative study of New South Wales metropolitan general practitioners
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
Buprenorphine is a partial opioid agonist commonly used to treat opioid dependence. The pharmacology of buprenorphine increases the risk of a precipitated opioid withdrawal when commencing patients on buprenorphine treatment, particularly when transferring from long acting opioids (e.g. methadone). There is little documented experience regarding the management of precipitated withdrawal. In our case, a patient developed a significant precipitated…
No prominent works on this page.
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
Buprenorphine is a partial opioid agonist commonly used to treat opioid dependence. The pharmacology of buprenorphine increases the risk of a precipitated opioid withdrawal when commencing patients on buprenorphine treatment, particularly when transferring from long acting opioids (e.g. methadone). There is little documented experience regarding the management of precipitated withdrawal. In our case, a patient developed a significant precipitated…
What do general practitioners want from specialist alcohol and other drug services? A qualitative study of New South Wales metropolitan general practitioners
The Whole Structure Is Knackered, It Could Still Explode, It Really Could”
Opioid dependence is a chronic health condition with significant public health implications. Opioid dependence treatment (ODT) has evolved considerably over time. In New South Wales, Australia, ODT prescribing has been available since 1970, managed by both state health services and private practitioners, mostly general practitioners (GPs). This study investigated how various health initiatives influenced GP engagement in ODT prescribing in New So…
Experiences and Predictors of Real‐Time Prescription Drug Monitoring Program Use Among Australian Community Pharmacists
Management of Opioid Withdrawal Syndrome and Commencement of Opioid Dependence Treatment Following Chronic Use of a Vaping Product Containing Protonitazene
Opioid Use Disorder Treatment (5 works) · Medicine (3 works) · Opioid (3 works) · Alcoholism and Thiamine Deficiency (2 works) · Buprenorphine (2 works) · Family medicine (2 works) · Medical prescription (2 works) · Nursing (2 works) · Opioid use disorder (2 works) · Substance Abuse Treatment and Outcomes (2 works)